Acute concern is created among drug information department staff in pharmaceutical firms whenever calls are received from individuals who seem deceitful. This paper lists some of the identifying characteristics of these calls, discusses the hazards involved in responding to these callers, and differentiates these calls from those by health care professionals who received disinformation. Measures are suggested to minimize the impact of deceptive callers.
